NIO Inc. vs Personalis Inc. Common Stock — how do they compare? NIO Inc. trades at $3.51 (market cap $8.76B), while Personalis Inc. Common Stock trades at $15.97 (market cap $1.70B). The key difference: NIO Inc. is far larger — about 5.2× Personalis Inc. Common Stock's market cap, and Personalis Inc. Common Stock is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NIO Inc. for 81 Days and Personalis Inc. Common Stock for 0 Days on average.
| NIO | PSNL | |
|---|---|---|
Market Cap | $8.76B | $1.70B |
Volume | 36,159,487 | 3,262,398 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.42 | $18.38 |
52-Week Low | $3.37 | $5.04 |
Typical Hold Time | 81 Days | 0 Days |
Enterprise Value | $6.65B | $1.52B |
Signals from Pluang's Aura AI — not financial advice
NIO trades at $3.56, up 2.59% today but remains near 52-week lows amid a bearish technical outlook. The Chinese EV maker shows improving fundamentals with revenue growth to $87.49B in 2025 and narrowing losses, though profitability remains elusive. Recent strategic moves include a battery-swap partnership with Geely valued at $2.38B, potentially expanding NIO's network reach and utilization.
While analyst consensus leans bullish with a $6.23 price target, significant risks persist including intense price competition in China's EV market, negative cash flows, and high debt levels. The stock offers speculative upside if execution improves, but requires monitoring of quarterly earnings and competitive dynamics.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →